Spectrum of clinically relevant Exophiala species in the United States

Journal of Clinical Microbiology

Volumn 45, Issue 11, 2007, Pages 3713-3720

  Zeng, J S ^a,b,c   Sutton, D A ^d   Fothergill, A W ^d   Rinaldi, M G ^d,e   Harrak, M J ^a,b   De Hoog, G S ^a,b  

^a CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^e SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; INTERNAL TRANSCRIBED SPACER; ITRACONAZOLE; POSACONAZOLE; RIBOSOME RNA; VORICONAZOLE;

ANTIBIOTIC SENSITIVITY; ARTICLE; EXOPHIALA; EXOPHIALA ATTENUATA; EXOPHIALA BERGERI; EXOPHIALA DERMATITIDIS; EXOPHIALA HETEROMORPHA; EXOPHIALA JEANSELMEI; EXOPHIALA LECANII CORNI; EXOPHIALA MESOPHILA; EXOPHIALA OLIGOSPERMA; EXOPHIALA PHAEOMURIFORMIS; EXOPHIALA SPINIFERA; EXOPHIALA XENOBIOTICA; FUNGAL DETECTION; FUNGAL STRAIN; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHIALOPHORA EUROPAEA; PRIORITY JOURNAL; SKIN INFECTION; UNITED STATES;

BRAIN; DNA, RIBOSOMAL SPACER; EXOPHIALA; HUMANS; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES; SKIN;

ANIMALIA; EXOPHIALA; EXOPHIALA ATTENUATA; EXOPHIALA BERGERI; EXOPHIALA DERMATITIDIS; EXOPHIALA HETEROMORPHA; EXOPHIALA JEANSELMEI; EXOPHIALA LECANII-CORNI; EXOPHIALA MESOPHILA; EXOPHIALA OLIGOSPERMA; EXOPHIALA SPINIFERA; PHIALOPHORA;

EID: 36348978165     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02012-06     Document Type: Article

References (40)

1. Al-Obaid, I., S. Ahmad, Z. U. Khan, B. Dinesh, and H. M. Hejab. 2006. Catheter-associated fungemia due to Exophiala oligosperma in a leukemic child and review of fungemia cases caused by Exophiala species. Eur. J. Clin. Microbiol. Infect. Dis. 25:729-732.
2. Anonymous. 2002. Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy-United States, July-November 2002. JAMA 289:291-293.
3. Blaschke-Hellmessen, R. 1996. Fluconazole and itraconazole susceptibility testing with clinical yeast isolates and algae of the genus Prototheca by means of the Etest. Mycoses 39(Suppl. 2):39-43.
4. Bossler, A. D., S. S. Richter, A. J. Chavez, S. A. Vogelgesang, D. A. Sutton, A. M. Grooters, M. G. Rinaldi, G. S. de Hoog, and M. A. Pfaller. 2003. Exophiala oligosperma causing olecranon bursitis. J. Clin. Microbiol. 41:4779-4782.
5. Campos-Takaki, G. M., and M. L. Jardim. 1994. Report of chronic subcutaneous abscesses caused by Exophiala spinifera. Mycopathologia 127:73-76.
6. Chang, C. L., D. S. Kim, D. J. Park, H. J. Kim, C. H. Lee, and J. H. Shin. 2000. Acute cerebral phaeohyphomycosis due to Wangiella dermatitidis accompanied by cerebrospinal fluid eosinophilia. J. Clin. Microbiol. 38:1965-1966.
7. Clancy, C. J., J. R. Wingard, and M. Hong Nguyen. 2000. Subcutaneous phaeohyphomycosis in transplant recipients: review of the literature and demonstration of in vitro synergy between antifungal agents. Med. Mycol. 38:169-175.
8. Clinical and Laboratory Standards Institute. 2002. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard M38-A. Clinical and Laboratory Standards Institute, Wayne, PA.
9. De Hoog, G. S., J. Guarro, J. Gené, and M. J. Figueras. 2000. Atlas of clinical fungi, 2nd ed. Centraalbureau voor Schimmelcultures/ Universitat Rovira i Virgili, Utrecht, The Netherlands.
10. De Hoog, G. S., A. H. G. Gerrits van den Ende, J. M. J. Uijthof, and W. A. Untereiner. 1995. Nutritional physiology of type isolates of currently accepted species of Exophiala and Phaeococcomyces. Antonie Leeuwenhoek 68:43-49.
11. De Hoog, G. S., and G. Haase. 1993. Nutritional physiology and selective isolation of Exophiala dermatitidis. Antonie Leeuwenhoek 64:17-26.
12. De Hoog, G. S., T. Matos, M. Sudhadham, K. F. Luijsterburg, and G. Haase. 2005. Intestinal prevalence of the neurotropic black yeast Exophiala (Wangiella) dermatitidis in healthy and impaired individuals. Mycoses 48:142-145.
13. De Hoog, G. S., N. Poonwan, and A. H. G. Gerrits van den Ende. 1999. Taxonomy of Exophiala spinifera and its relationship to E. jeanselmei. Stud. Mycol. 43:133-142.
14. De Hoog, G. S., K. Takeo, S. Yoshida, E. Göttlich, K. Nishimura, and M. Miyaji. 1994. Pleoanamorphic life cycle of Exophiala (Wangiella) dermatitidis. Antonie Leeuwenhoek 65:143-153.
15. De Hoog, G. S., V. Vicente, R. B. Caligiorne, S. Kantarcioglu, K. Tintelnot, A. H. G. Gerrits van den Ende, and G. Haase. 2003. Species diversity and polymorphism in the Exophiala spinifera clade containing opportunistic black yeast-like fungi. J. Clin. Microbiol. 41:4767-4778.
16. De Hoog, G. S., J. S. Zeng, M. J. Harrak, and D. A. Sutton. 2006. Exophiala xenobiotica sp. nov., an opportunistic black yeast inhabiting environments rich in hydrocarbons. Antonie Leeuwenhoek 90:257-268.
17. De Rijk, P., and R. De Wachter. 1993. DCSE v. 2.54, an interactive tool for sequence alignment and secondary structure research. Comput. Appl. Biosci. 9:735-740.
18. Dlemert, D., D. Kunimoto, C. Sand, and R. Rennie. 2001. Sputum isolation of Wangiella dermatitidis in patients with cystic fibrosis. Scand. J. Infect. 33:777-779.
19. Engemann, J., K. Kaye, G. Cox, J. Perfect, W. Schell, S. A. McGarry, K. Patterson, S. Edupuganti, P. Cook, W. A. Rutala, D. J. Weber, K. K. Hoffmann, J. Engel, S. Young, E. Durant, K. McKinnon, N. Cobb, L. Bell, J. Gibson, D. Jernigan, M. Arduino, S. Fridkin, L. Archibald, L. Sehulster, J. Morgan, R. Hajjeh, M. Brandt, D. Warnock, and W. A. Duffus. 2002. Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy-United States. July-November 2002. Morb. Mortal. Wkly. Rep. 51:1109-1112.
20. Gerrits van den Ende, A. H. G., and G. S. de Hoog. 1999. Variability and molecular diagnostics of the neurotropic species Cladophialophora bantiana. Stud. Mycol. 43:151-162.
21. Haase, G., H. Skopnik, T. Groten, G. Kusenbach, and H. G. Posselt. 1991. Long-term fungal cultures from patients with cvstic fibrosis. Mycoses 34:373-376.
22. Haase, G., L. Sonntag, B. Melzer-Krick, and G. S. de Hoog. 1999. Phylogenetic interference by SSU-gene analysis of members of the Herpotrichiellaceae with special reference to human pathogenic species. Stud. Mycol. 43:80-97.
23. Hiruma, M., A. Kawada, H. Ohata, Y. Ohnishi, H. Takahashi, M. Yamazaki, A. Ishibashi, K. Hatsuse, M. Kakihara, and M. Yoshida. 1993. Systemic phaeohyphomycosis caused by Exophiala dermatitidis. Mycoses 36:1-7.
24. Horré, R., K. P. Schaal, R. Siekmeier, B. Sterzik, G. S. de Hoog, and N. Schnitzler. 2004. Isolation of fungi, especially Exophiala dermatitidis, in patients suffering from cystic fibrosis: a prospective study. Respiration 71:360-366.
25. Li, D., R. Li, D. Wang, and S. Ma. 1999. In vitro activities of five antifungal agents against pathogenic Exophiala species. Chin. Med. J. 112:484-488.
26. Matsumoto, T., T. Matsuda, M. R. McGinnis, and L. Ajello. 1993. Clinical and mycological spectra of Wangiella dermatitidis infections. Mycoses 36:145-155.
27. Meletiadis, J., J. F. Meis, G. S. de Hoog, and P. E. Verweij. 2000. In vitro susceptibilities of 11 clinical isolates of Exophiala species to six antifungal drugs. Mycoses 43:309-312.
28. Murray, I. G., G. E. Dunkerley, and K. E. A. Hughes. 1964. A case of Madura foot caused by Phialophora jeanselmei. Sabouraudia 3:175-177.
29. Myoken, Y., T. Sugata, Y. Fujita, T. Kyo, M. Fujihara, M. Katsu, and Y. Mikami. 2003. Successful treatment of invasive stomatitis due to Exophiala dermatitidis in a patient with acute myeloid leukemia. J. Oral Pathol. Med. 32:51-54.
30. Naka, W., T. Harada, T. Nishikawa, and R. Fukushiro. 1986. A case of chromoblastomycosis: with special reference to the mycology of the isolated Exophiala jeanselmei. Mykosen 29:445-452.
31. Negroni, R., S. H. Helou, N. Petri, A. M. Robles, A. Arechavala, and M. H. Bianchi. 2004. Case study: posaconazole treatment of disseminated phaeohyphomycosis due to Exophiala spinifera. Clin. Infect. Dis. 38:15-20.
32. + T lymphocytopenia. Mycoses 38:271-276.
33. Nucci, M., T. Akiti, G. Barreiros, F. Silveira, S. G. Revankar, D. A. Sutton, and T. F. Patterson. 2001. Nosocomial fungemia due to Exophiala jeanselmei var. jeanselmei and a Rhinocladiella species: newly described causes of blood-stream infection. J. Clin. Microbiol. 39:514-518.
34. Nucci, M., T. Akiti, G. Barreiros, F. Silveira, S. G. Revankar, B. L. Wickes, D. A. Sutton, and T. F. Patterson. 2002. Nosocomial outbreak of Exophiala jeanselmei fungemia associated with contamination of hospital water. Clin. Infect. Dis. 34:1475-1480.
35. Padhye, A. A., A. A. Hampton, M. T. Hampton, N. W. Hutton, E. Prevost- Smith, and M. S. Davis. 1996. Chromoblastomycosis caused by Exophiala spinifera. Clin. Infect. Dis. 22:331-335.
36. Rajendran, C., B. K. Khaitan, R. Mittal, M. Ramam, M. Bhardwaj, and K. K. Datta. 2003. Phaeohyphomycosis caused by Exophiala spinifera in India. Med. Mycol. 41:437-441.
37. Tintelnot, K., G. S. de Hoog, E. Thomas, W.-I. Steudel, K. Huebner, and H. P. R. Seeliger. 1991. Cerebral phaeohyphomycosis caused by an Exophiala species. Mycoses 34:239-244.
38. Van de Peer, Y., and R. De Wachter. 1994. Treecon for Windows: a software package for the construction and drawing of evolutionary trees for the Microsoft Windows environment. Comput. Appl. Biosci. 10:569-570.
39. Vitale, R. G., and G. S. de Hoog. 2002. Molecular diversity, new species and antifungal susceptibilities in the Exophiala spinifera clade. Med. Mycol. 40:545-556.
40. Wang, D., R. Li, X. Wang, and W. Dai. 1987. Studies on three strains of Exophiala spinifera. Acta Mycol. Sin. 6:229-232.